{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:39:26Z","timestamp":1793410766562,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atorvastatin (ATO) is a widely prescribed lipid-lowering drug, but its use can be limited by hepatotoxicity, potentially linked to metabolism-related mechanisms. The cellular pathways connecting ATO metabolism to oxidative imbalance and apoptotic alterations remain incompletely defined. This study examined the roles of oxidative stress, mitochondrial-associated apoptosis, and the pregnane X receptor (PXR)\u2013CYP3A4 axis in ATO-induced hepatic changes, and evaluated whether coenzyme Q10 (CoQ10) could modulate these effects depending on administration timing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Forty male albino rats were randomly assigned to four groups (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910). Group I received vehicle (5% DMSO\u2009+\u2009olive oil), Group II received atorvastatin (ATO, 80\u00a0mg\/kg), Group III received ATO (80\u00a0mg\/kg) plus CoQ10 (10\u00a0mg\/kg), and Group IV received ATO for 21 days followed by CoQ10 for 21 days. All treatments were administered orally once daily. Hepatic outcomes were assessed using biochemical markers, histopathology, and Bcl-2 immunohistochemistry. Microsomal CYP3A1 (rat ortholog of human CYP3A4) catalytic activity was determined using a testosterone 6\u03b2-hydroxylation assay. Molecular docking evaluated interactions of ATO, its lactone metabolite, and CoQ10 with CYP3A4 and PXR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ATO induced oxidative imbalance, evidenced by increased lipid peroxidation and nitric oxide alongside depleted antioxidant defenses, accompanied by liver structural alterations and reduced Bcl-2 expression. ATO significantly reduced hepatic microsomal CYP3A1 activity to ~\u200929% of vehicle control (~\u200971% decrease). CoQ10 co-administration markedly attenuated these effects, restoring redox homeostasis and increasing Bcl-2 expression, while co-treatment restored CYP3A1 activity (~\u200990% of vehicle control). Post-treatment with CoQ10 partially restored CYP3A1 activity (~\u200960% of vehicle control). Docking analysis indicated favorable binding of ATO and its lactone to CYP3A4 and PXR, supporting metabolism-linked bioactivation, while CoQ10 exhibited lower affinity, suggesting indirect modulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ATO-induced hepatic injury is associated with oxidative stress and mitochondrial-related apoptotic processes linked to metabolism-dependent mechanisms. Functional impairment of CYP3A1 activity accompanied ATO-induced oxidative damage, whereas CoQ10 preserved enzymatic activity, consistent with hepatocellular protection. Early CoQ10 intervention provided superior protection, highlighting the importance of timing in mitigating metabolism-related hepatic damage. These findings provide mechanistic insight into statin-induced hepatotoxicity and support further investigation of CoQ10 as a complementary strategy to enhance statin safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40360-026-01125-z","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:25:28Z","timestamp":1775708728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Coenzyme Q10 protects against atorvastatin-induced hepatotoxicity via attenuation of oxidative stress and functional modulation of CYP3A1"],"prefix":"10.1186","volume":"27","author":[{"given":"Mohammed A.","family":"Abdel-Rasol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda A.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-1417","authenticated-orcid":false,"given":"Wael M.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud","family":"AbdelRaouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"1","key":"1125_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s43094-025-00788-5","volume":"11","author":"AK Saleh","year":"2025","unstructured":"Saleh AK, El-Masry TA, El-Kadem AH, Ashour NA, El-Mahdy NA. Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents. Future J Pharm Sci. 2025;11(1):38. https:\/\/doi.org\/10.1186\/s43094-025-00788-5.","journal-title":"Future J Pharm Sci"},{"issue":"2","key":"1125_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.18502\/aptj.v5i2.19453","volume":"5","author":"M Mashhadi Akbar Boojar","year":"2025","unstructured":"Mashhadi Akbar Boojar M, Bagheri A, Mashhadi Akbar Boojar M. A review of liver damage caused by statins. Adv Pharmacol Ther J. 2025;5(2):45\u201356. https:\/\/doi.org\/10.18502\/aptj.v5i2.19453.","journal-title":"Adv Pharmacol Ther J"},{"issue":"7","key":"1125_CR3","doi-asserted-by":"publisher","first-page":"e0327500","DOI":"10.1371\/journal.pone.0327500","volume":"20","author":"L Zhou","year":"2025","unstructured":"Zhou L, Wu B, Bian Y, Lu Y, Zou Y, Lin S, Li Q, Liu C. Hepatotoxicity associated with statins: A retrospective pharmacovigilance study based on the FAERS database. PLoS ONE. 2025;20(7):e0327500. https:\/\/doi.org\/10.1371\/journal.pone.0327500.","journal-title":"PLoS ONE"},{"issue":"9","key":"1125_CR4","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/ph18091351","volume":"18","author":"M Hern\u00e1ndez-Lorca","year":"2025","unstructured":"Hern\u00e1ndez-Lorca M, Tim\u00f3n IM, Ballester P, Henarejos-Escudero P, Garc\u00eda-Mu\u00f1oz AM, Victoria-Montesinos D, Barcina-P\u00e9rez P. Dietary Modulation of CYP3A4 and Its Impact on Statins and Antidiabetic Drugs: A Narrative Review. Pharmaceuticals. 2025;18(9):1351. https:\/\/doi.org\/10.3390\/ph18091351.","journal-title":"Pharmaceuticals"},{"issue":"2\u20133","key":"1125_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ejphar.2011.03.047","volume":"660","author":"WM El-Sayed","year":"2011","unstructured":"El-Sayed WM. Effect of pregnane X receptor (PXR) prototype agonists on chemoprotective and drug metabolizing enzymes in mice. Eur J Pharmacol. 2011;660(2\u20133):291\u20137. https:\/\/doi.org\/10.1016\/j.ejphar.2011.03.047.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1125_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1186\/s40001-025-03073-6","volume":"30","author":"MA Abdel-Rasol","year":"2025","unstructured":"Abdel-Rasol MA, El-Sayed WM. Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions. Eur J Med Res. 2025;30(1):843. https:\/\/doi.org\/10.1186\/s40001-025-03073-6.","journal-title":"Eur J Med Res"},{"key":"1125_CR7","doi-asserted-by":"publisher","unstructured":"Shi Z, Han S. Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins. Heliyon. 2025;11(1). https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41629.","DOI":"10.1016\/j.heliyon.2025.e41629"},{"issue":"12","key":"1125_CR8","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.3390\/nu16121954","volume":"16","author":"RT Cristina","year":"2024","unstructured":"Cristina RT, Mohamed EA, Tulcan C, Dumitrescu E, Muselin F, Or\u0103\u0219an SA, Mateoc-Sirb T, Vlad D. The oxidative stress markers\u2019 protective influence of sea buckthorn and grape extracts in atorvastatin-treated hyperlipidemic rats. Nutrients. 2024;16(12):1954. https:\/\/doi.org\/10.3390\/nu16121954.","journal-title":"Nutrients"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"110956","DOI":"10.1016\/j.cbi.2024.110956","volume":"393","author":"D Li","year":"2024","unstructured":"Li D, Chen J, Zhou F, Zhang W, Chen H. Aldo-keto reductase-7A2 protects against atorvastatin-induced hepatotoxicity via Nrf2 activation. Chem Biol Interact. 2024;393:110956. https:\/\/doi.org\/10.1016\/j.cbi.2024.110956.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"1125_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s43094-025-00788-5","volume":"11","author":"AK Saleh","year":"2025","unstructured":"Saleh AK, El-Masry TA, El-Kadem AH, Ashour NA, El-Mahdy NA. Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents. Future J Pharm Sci. 2025;11(1):38. https:\/\/doi.org\/10.1186\/s43094-025-00788-5.","journal-title":"Future J Pharm Sci"},{"issue":"4","key":"1125_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41418-024-01284-8","volume":"31","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Arroum T, Luo X, Kang R, Lee YJ, Tang D, H\u00fcttemann M, Song X. Diverse functions of cytochrome c in cell death and disease. Cell Death Differ. 2024;31(4):387\u2013404. https:\/\/doi.org\/10.1038\/s41418-024-01284-8.","journal-title":"Cell Death Differ"},{"issue":"5","key":"1125_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.53388\/TMR20231022001","volume":"9","author":"MJ Liao","year":"2024","unstructured":"Liao MJ, Li Q, Luo QY, Chen XY, Chen JY, He Y. Pharmacological effects of Ginkgo biloba and its active ingredients in the treatment of cardiovascular diseases. Tradit Med Res. 2024;9(5):26. https:\/\/doi.org\/10.53388\/TMR20231022001.","journal-title":"Tradit Med Res"},{"issue":"12","key":"1125_CR13","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.3390\/ijms26125788","volume":"26","author":"D Mantle","year":"2025","unstructured":"Mantle D, Golomb BA. Coenzyme Q10 and Xenobiotic Metabolism: An Overview. Int J Mol Sci. 2025;26(12):5788. https:\/\/doi.org\/10.3390\/ijms26125788.","journal-title":"Int J Mol Sci"},{"key":"1125_CR14","doi-asserted-by":"publisher","unstructured":"Keshavarzi M, Naraki K, Razavi BM, Hosseinzadeh H. Ameliorative and protective effects of coenzyme Q10 against natural and chemical toxicity: a narrative review. Naunyn Schmiedebergs Arch Pharmacol. 2025:1\u201334. https:\/\/doi.org\/10.1007\/s00210-025-03992-5.","DOI":"10.1007\/s00210-025-03992-5"},{"issue":"10","key":"1125_CR15","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/antiox14101147","volume":"14","author":"F Valenti","year":"2025","unstructured":"Valenti F, Pincigher L, Rizzardi N, Orsini F, Bergamini C, Fato R. Atorvastatin Induces Bioenergetic Impairment and Oxidative Stress Through Reverse Electron Transport. Antioxidants. 2025;14(10):1147. https:\/\/doi.org\/10.3390\/antiox14101147.","journal-title":"Antioxidants"},{"issue":"1","key":"1125_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.biopha.2013.09.001","volume":"68","author":"MA El-Moselhy","year":"2014","unstructured":"El-Moselhy MA, El-Sheikh AA. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity. Biomed Pharmacother. 2014;68(1):101\u201310. https:\/\/doi.org\/10.1016\/j.biopha.2013.09.001.","journal-title":"Biomed Pharmacother"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.lfs.2018.04.034","volume":"203","author":"SM Farrag","year":"2018","unstructured":"Farrag SM, Hamzawy MA, El-Yamany MF, Saad MA, Nassar NN. Atorvastatin in nano-particulate formulation abates muscle and liver affliction when coalesced with coenzyme Q10 and\/or vitamin E in hyperlipidemic rats. Life Sci. 2018;203:129\u201340. https:\/\/doi.org\/10.1016\/j.lfs.2018.04.034.","journal-title":"Life Sci"},{"key":"1125_CR18","doi-asserted-by":"publisher","unstructured":"De Leon JAD, Borges CR. Evaluation of oxidative stress in biological samples using the thiobarbituric acid reactive substances assay. J Vis Exp. 2020:15910\u20133791. https:\/\/doi.org\/10.3791\/61122.","DOI":"10.3791\/61122"},{"issue":"1","key":"1125_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11172-019-2434-2","volume":"68","author":"ZV Kuropteva","year":"2019","unstructured":"Kuropteva ZV, Baider LM, Nagler LG, Bogatyrenko TN, Belaia OL. l-Arginine and nitric oxide synthesis in the cells with inducible NO synthase. Russ Chem Bull. 2019;68(1):174\u201380. https:\/\/doi.org\/10.1007\/s11172-019-2434-2.","journal-title":"Russ Chem Bull"},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.vascn.2017.05.004","volume":"88","author":"T L\u0151rincz","year":"2017","unstructured":"L\u0151rincz T, Szarka A. The determination of hepatic glutathione at tissue and subcellular level. J Pharmacol Toxicol Methods. 2017;88:32\u20139. https:\/\/doi.org\/10.1016\/j.vascn.2017.05.004.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"4","key":"1125_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00534-002-0824-5","volume":"10","author":"S Szymonik-Lesiuk","year":"2003","unstructured":"Szymonik-Lesiuk S, Czechowska G, Stryjecka-Zimmer M, S\u0142omka M, M\u0105dro A, Celi\u0144ski K, Wielosz M. Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepatobiliary Pancreat Surg. 2003;10(4):309\u201315. https:\/\/doi.org\/10.1007\/s00534-002-0824-5.","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"3","key":"1125_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF02712155","volume":"13","author":"A Nandi","year":"1988","unstructured":"Nandi A, Chatterjee IB. Assay of superoxide dismutase activity in animal tissues. J Biosci. 1988;13(3):305\u201315. https:\/\/doi.org\/10.1007\/BF02712155.","journal-title":"J Biosci"},{"issue":"5","key":"1125_CR23","doi-asserted-by":"publisher","first-page":"e0323531","DOI":"10.1371\/journal.pone.0323531","volume":"20","author":"L Xie","year":"2025","unstructured":"Xie L, Zhang Z, Chen Y, Li J, Wang Y, Liu J, Zhao Q, Chen X, Zhang Y. Assessing liver function in rat models of acute liver failure using single-photon emission computed tomography and cytokine levels. PLoS ONE. 2025;20(5):e0323531. https:\/\/doi.org\/10.1371\/journal.pone.0323531.","journal-title":"PLoS ONE"},{"issue":"9","key":"1125_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1139\/y11-060","volume":"89","author":"WM El-Sayed","year":"2011","unstructured":"El-Sayed WM, Al-Kahtani MA. Potential adverse effects of oseltamivir in rats: males are more vulnerable than females. Can J Physiol Pharmacol. 2011;89(9):623\u201330. https:\/\/doi.org\/10.1139\/y11-060.","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"1125_CR25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/plants12040934","volume":"12","author":"V Mani","year":"2023","unstructured":"Mani V, Arfeen M, Dhaked DK, Mohammed HA, Amirthalingam P, Elsisi HA. Neuroprotective effect of methanolic Ajwa seed extract on lipopolysaccharide-induced memory dysfunction and neuroinflammation: In vivo, molecular docking and dynamics studies. Plants. 2023;12(4):934. https:\/\/doi.org\/10.3390\/plants12040934.","journal-title":"Plants"},{"issue":"8","key":"1125_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3923\/ijp.2023.938.946","volume":"19","author":"A Icel","year":"2023","unstructured":"Icel A, Suleyman B, Mammadov R, Bulut S, Cicek B, Yazici GN, Gulaboglu M, Ozcicek F, Suleyman H. Effect of Liv-52 on Atorvastatin Induced Hepatotoxicity in Rats: A Biochemical and Histopathologic Study. Int J Pharmacol. 2023;19(8):938\u201346. https:\/\/doi.org\/10.3923\/ijp.2023.938.946.","journal-title":"Int J Pharmacol"},{"key":"1125_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.fct.2015.05.016","volume":"83","author":"S Pal","year":"2015","unstructured":"Pal S, Ghosh M, Ghosh S, Bhattacharyya S, Sil PC. Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways. Food Chem Toxicol. 2015a;83:36\u201347. https:\/\/doi.org\/10.1016\/j.fct.2015.05.016.","journal-title":"Food Chem Toxicol"},{"key":"1125_CR28","doi-asserted-by":"publisher","first-page":"33072","DOI":"10.1038\/srep33072","volume":"6","author":"N Shu","year":"2016","unstructured":"Shu N, Hu M, Ling Z, Liu P, Wang F, Xu P, Zhong Z, Sun B, Zhang M, Li F, Xie Q. The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1. Sci Rep. 2016;6:33072. https:\/\/doi.org\/10.1038\/srep33072.","journal-title":"Sci Rep"},{"issue":"8","key":"1125_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.32383\/farmpol\/197743","volume":"80","author":"M Belczyk","year":"2024","unstructured":"Belczyk M, Knapik-Czajka M, Gaw\u0119dzka A, Dr\u0105g J. The effects of statins on mitochondria\u2014the current state of knowledge. Farm Pol. 2024;80(8):579\u201387. https:\/\/doi.org\/10.32383\/farmpol\/197743.","journal-title":"Farm Pol"},{"issue":"2","key":"1125_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/antiox14020203","volume":"14","author":"M Fu","year":"2025","unstructured":"Fu M, Yoon KS, Ha J, Kang I, Choe W. Crosstalk between antioxidants and adipogenesis: mechanistic pathways and their roles in metabolic health. Antioxidants. 2025;14(2):203. https:\/\/doi.org\/10.3390\/antiox14020203.","journal-title":"Antioxidants"},{"issue":"4","key":"1125_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.64062\/JPGMB.Vol1.Issue4.9","volume":"1","author":"ZK Shivubha","year":"2025","unstructured":"Shivubha ZK. Genome-wide association study of statin-induced myopathy. J Pharmacol Genet Mol Biol. 2025;1(4):99\u2013109. https:\/\/doi.org\/10.64062\/JPGMB.Vol1.Issue4.9.","journal-title":"J Pharmacol Genet Mol Biol"},{"issue":"1","key":"1125_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13105-013-0296-x","volume":"70","author":"TK Motawi","year":"2014","unstructured":"Motawi TK, Teleb ZA, El-Boghdady NA, Ibrahim SA. Effect of simvastatin and naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: an in vivo and in vitro study. J Physiol Biochem. 2014;70(1):225\u201337. https:\/\/doi.org\/10.1007\/s13105-013-0296-x.","journal-title":"J Physiol Biochem"},{"issue":"1","key":"1125_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40168-017-0312-4","volume":"5","author":"JA Caparr\u00f3s-Mart\u00edn","year":"2017","unstructured":"Caparr\u00f3s-Mart\u00edn JA, Lareu RR, Ramsay JP, Peplies J, Reen FJ, Headlam HA, Ward NC, Croft KD, Newsholme P, Hughes JD, O\u2019Gara F. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. Microbiome. 2017;5(1):95. https:\/\/doi.org\/10.1186\/s40168-017-0312-4.","journal-title":"Microbiome"},{"issue":"3","key":"1125_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.14218\/JCTH.2021.00271","volume":"10","author":"LD Averbukh","year":"2022","unstructured":"Averbukh LD, Turshudzhyan A, Wu DC, Wu GY. Statin-induced liver injury patterns: a clinical review. J Clin Transl Hepatol. 2022;10(3):543. https:\/\/doi.org\/10.14218\/JCTH.2021.00271.","journal-title":"J Clin Transl Hepatol"},{"key":"1125_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.biochi.2015.02.016","volume":"112","author":"S Pal","year":"2015","unstructured":"Pal S, Sarkar A, Pal PB, Sil PC. Protective effect of arjunolic acid against atorvastatin induced hepatic and renal pathophysiology via MAPK, mitochondria and ER dependent pathways. Biochimie. 2015b;112:20\u201334. https:\/\/doi.org\/10.1016\/j.biochi.2015.02.016.","journal-title":"Biochimie"},{"key":"1125_CR36","doi-asserted-by":"publisher","unstructured":"Adabi R, Masoudi A, Rafaiee R, Mohseni F. Coenzyme Q10 as an adjunctive treatment for substance use disorders: a preclinical review. J Addict Dis. 2025:1\u201311. https:\/\/doi.org\/10.1080\/10550887.2025.2521561.","DOI":"10.1080\/10550887.2025.2521561"},{"issue":"6","key":"1125_CR37","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/ijms23063315","volume":"23","author":"M Mihajlovic","year":"2022","unstructured":"Mihajlovic M, Vinken M. Mitochondria as the target of hepatotoxicity and drug-induced liver injury: molecular mechanisms and detection methods. Int J Mol Sci. 2022;23(6):3315. https:\/\/doi.org\/10.3390\/ijms23063315.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1125_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s41100-023-00508-w","volume":"9","author":"G Cusumano","year":"2023","unstructured":"Cusumano G, Cola E, Spagnoletti G, Severino A, Giubilato S, Stigliano E, Caristo ME, Vischini G, Liuzzo G, Salerno MP, Crea F. High-dose atorvastatin reduces oxidative stress of ischemia\/reperfusion injury after isogeneic kidney transplantation in rats: in vivo, preclinical, case\u2013control, open-label study. Ren Replace Ther. 2023;9(1):57. https:\/\/doi.org\/10.1186\/s41100-023-00508-w.","journal-title":"Ren Replace Ther"},{"issue":"7","key":"1125_CR39","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00210-021-02070-w","volume":"394","author":"OY Alshogran","year":"2021","unstructured":"Alshogran OY, Nusair SD, El-Elimat T, Alzoubi KH, Obeidat A, Sweidan M. Evaluation of coenzyme Q10 combined with or without N-acetyl cysteine or atorvastatin for preventing contrast-induced kidney injury in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(7):1403\u201310. https:\/\/doi.org\/10.1007\/s00210-021-02070-w.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"1125_CR40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s10194-025-01957-w","volume":"15","author":"E Khaleqsefat","year":"2025","unstructured":"Khaleqsefat E, Rasul KH, Kheder RK, Baban S, Baban J. Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients. Sci Rep. 2025;15(1):288. https:\/\/doi.org\/10.1186\/s10194-025-01957-w.","journal-title":"Sci Rep"},{"key":"1125_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biochi.2022.08.018","volume":"204","author":"SX Mthembu","year":"2023","unstructured":"Mthembu SX, Orlando P, Silvestri S, Ziqubu K, Mazibuko-Mbeje SE, Mabhida SE, Nyambuya TM, Nkambule BB, Muller CJ, Basson AK, Tiano L. Impact of dyslipidemia in the development of cardiovascular complications: delineating the potential therapeutic role of coenzyme Q10. Biochimie. 2023;204:33\u201340. https:\/\/doi.org\/10.1016\/j.biochi.2022.08.018.","journal-title":"Biochimie"},{"key":"1125_CR42","doi-asserted-by":"publisher","first-page":"1358567","DOI":"10.3389\/fphar.2024.1358567","volume":"15","author":"YA Park","year":"2024","unstructured":"Park YA, Chang Y, Lee DH, Kim JS, Park M, Choi SA, Song TJ, Gwak HS. Association between coenzyme Q10-related genetic polymorphisms and statin-associated myotoxicity in Korean stroke patients. Front Pharmacol. 2024;15:1358567. https:\/\/doi.org\/10.3389\/fphar.2024.1358567.","journal-title":"Front Pharmacol"},{"key":"1125_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejphar.2015.05.041","volume":"762","author":"A Mohammadi-Bardbori","year":"2015","unstructured":"Mohammadi-Bardbori A, Najibi A, Amirzadegan N, Gharibi R, Dashti A, Omidi M, Saeedi A, Ghafarian-Bahreman A, Niknahad H. Coenzyme Q10 remarkably improves the bio-energetic function of rat liver mitochondria treated with statins. Eur J Pharmacol. 2015;762:270\u20134. https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.041.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"1125_CR44","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1017\/S0007114525000637","volume":"133","author":"X Mao","year":"2025","unstructured":"Mao X, Li X, Wang L, Song K, Zhang C, Huang B, Lu K, Rahimnejad S. Coenzyme Q10 mitigates high-fat-diet-induced hepatic steatosis in spotted bass (Lateolabrax maculatus) through modulating mitochondrial function. Br J Nutr. 2025;133(8):1032\u201346. https:\/\/doi.org\/10.1017\/S0007114525000637.","journal-title":"Br J Nutr"},{"issue":"1","key":"1125_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1139\/cjpp-2017-0599","volume":"96","author":"SS Hassan","year":"2018","unstructured":"Hassan SS, Razzaque A, Ahmad Z, Pazdernik V, Amin SN. Does posttreatment thymoquinone reverse high-dose atorvastatin-induced hepatic oxidative injury in rats? Can J Physiol Pharmacol. 2018;96(1):51\u20139. https:\/\/doi.org\/10.1139\/cjpp-2017-0599.","journal-title":"Can J Physiol Pharmacol"},{"key":"1125_CR46","doi-asserted-by":"publisher","first-page":"1399598","DOI":"10.3389\/fphar.2024.1399598","volume":"15","author":"P Liu","year":"2024","unstructured":"Liu P, Liang WL, Huang RT, Chen XX, Zou DH, Kurihara H, Li YF, Xu YH, Ouyang SH, He RR. Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine. Front Pharmacol. 2024;15:1399598. https:\/\/doi.org\/10.3389\/fphar.2024.1399598.","journal-title":"Front Pharmacol"},{"key":"1125_CR47","doi-asserted-by":"publisher","unstructured":"Hashemi M, Raesi R, Pakshad B, Fard AA, Atashani FN, Mirzaie M, Atabi F, Shahpasand K, Nabavi N, Farahani N, Taheriazam A. Apoptosis: basics and role in pathological diseases. In Autophagy apoptosis ferroptosis oncology: cell death cancer. 2025. p. 265\u2013315. https:\/\/doi.org\/10.1142\/14017.","DOI":"10.1142\/14017"},{"issue":"10","key":"1125_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20(10):633\u201346. https:\/\/doi.org\/10.1038\/s41575-023-00807-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1125_CR49","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.12659\/MSM.915790","volume":"25","author":"H Zeng","year":"2019","unstructured":"Zeng H, Liu Z. Atorvastatin induces hepatotoxicity in diabetic rats via oxidative stress, inflammation, and anti-apoptotic pathway. Med Sci Monit. 2019;25:6165. https:\/\/doi.org\/10.12659\/MSM.915790.","journal-title":"Med Sci Monit"},{"issue":"1","key":"1125_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000527231","volume":"108","author":"L Qin","year":"2023","unstructured":"Qin L, Wang Y, Liang Y, Li Q, Xie X, Zhang H. Astragaloside Iv alleviates atorvastatin-induced hepatotoxicity via Ampk\/Sirt1 pathway. Pharmacology. 2023;108(1):74\u201382. https:\/\/doi.org\/10.1159\/000527231.","journal-title":"Pharmacology"},{"key":"1125_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.toxlet.2021.02.008","volume":"342","author":"N Zheng","year":"2021","unstructured":"Zheng N, Wei A, Wu T, Long L, Yang H, Li H, Wang L. Triptolide and atorvastatin synergistically promote hepatotoxicity in cultured hepatocytes and female Sprague-Dawley rats by inhibiting pregnane X receptor-mediated transcriptional activation of CYP3A4. Toxicol Lett. 2021;342:85\u201394. https:\/\/doi.org\/10.1016\/j.toxlet.2021.02.008.","journal-title":"Toxicol Lett"},{"issue":"3","key":"1125_CR52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/0115734080298814240528092106","volume":"20","author":"DI Boyarintsev","year":"2024","unstructured":"Boyarintsev DI, Kuzminov IV, Orlova MV. New Aspects in the Mechanism of Action of 3-hydroxy-3-methylglutaryl-COA Reductase (HMG-CoA reductase): Cyclic Lactones-Potential Inhibitors of the Enzyme. Curr Enzyme Inhib. 2024;20(3):164\u201372. https:\/\/doi.org\/10.2174\/0115734080298814240528092106.","journal-title":"Curr Enzyme Inhib"},{"issue":"9","key":"1125_CR53","doi-asserted-by":"publisher","first-page":"bvaf119","DOI":"10.1210\/jendso\/bvaf119","volume":"9","author":"K Ikeda","year":"2025","unstructured":"Ikeda K, Horie K, Inoue S, Blumberg B. Physiological Functions and Pathological Roles of PXR. J Endocr Soc. 2025;9(9):bvaf119. https:\/\/doi.org\/10.1210\/jendso\/bvaf119.","journal-title":"J Endocr Soc"},{"key":"1125_CR54","doi-asserted-by":"publisher","unstructured":"Zhu LL, Yu LY, Wang YH, Zhou Q. CYP2C8-Mediated drug\u2013drug interactions and the factors influencing the interaction magnitude. Drug Des Devel Ther. 2025:8391\u2013413. https:\/\/doi.org\/10.2147\/DDDT.S541536.","DOI":"10.2147\/DDDT.S541536"},{"issue":"1","key":"1125_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/toxsci\/kfab023","volume":"181","author":"AI Shehu","year":"2021","unstructured":"Shehu AI, Zhu J, Li J, Lu J, McMahon D, Xie W, Gonzalez FJ, Ma X. Targeting xenobiotic nuclear receptors PXR and CAR to prevent cobicistat hepatotoxicity. Toxicol Sci. 2021;181(1):58\u201367. https:\/\/doi.org\/10.1093\/toxsci\/kfab023.","journal-title":"Toxicol Sci"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01125-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01125-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01125-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:45:21Z","timestamp":1775817921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01125-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01125-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Institutional Ethics Committee, Faculty of Science, Ain Shams University (ASU-SCI\/ZOOL\/2025\/11\/01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}